| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Acadia Pharmaceuticals Inc. (ACAD) has 12 insiders with recent SEC Form 4 filings, including 14 buys and 9 sells. ACAD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 66.1K | $1.88M | - | |
| 10% | 32.0K | $910.6K | - | |
| VP | 19.0K | $540.4K | -16,558 | |
| CEO | 14.8K | $421.1K | - | |
| Other | 13.1K | $372.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2019 | Stankovic Srdjan R.62 | President | Sale+OE | 1,031 | $39.65 | $40,879.15 | -34.7% | |
| Oct 10, 2019 | Davis Stephen68 | CEO | Sale+OE | 150,000 | $40.15 | $6,022,749.10 | -100% | |
| Sep 20, 2019 | Baker Bros. Advisors LP59 | Director, 10% Owner | Buy | 1,562,500 | $40.00 | $62,500,000.00 | +4.0% | |
| Sep 11, 2019 | Miller Eric Alejandro | Controller &Pao | Sale+OE | 33,112 | $39.73 | $1,315,442.93 | -87.7% | |
| Sep 9, 2019 | Daly James M | Director | Sale+OE | 30,000 | $37.80 | $1,133,860.08 | -98.7% | |
| Jan 9, 2019 | Brege Laura62 | Director | Sale+OE | 10,000 | $20.00 | $200,041.00 | -100% | |
| Nov 30, 2018 | Baker Bros. Advisors LP59 | Director, 10% Owner | Buy | 11,764,705 | $17.00 | $199,999,985.00 | +42.1% | |
| Sep 20, 2018 | Baker Bros. Advisors LP59 | Director, 10% Owner | Buy | 1,210,776 | $18.70 | $22,646,989.19 | +1.5% | |
| Mar 2, 2018 | Soland Daniel B | Director | Buy | 10,000 | $23.49 | $234,910.00 | +71.4% | |
| Jan 29, 2018 | Baity Glenn | EVP And GC | Sell | 36,558 | $32.39 | $1,184,055.13 | -30.4% |